Gujarat Inject (Kerala) Ltd

Mon 7/09/2026,14:43:0 | BSE : GUJINJEC

₹11.110.01 (0.09%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 11.10

Previous Close

₹ 11.10

Volume

186013

Mkt Cap ( ₹ Cr)

₹ 162.75

High

₹ 11.65

Low

₹ 10.61

52 Week High

₹ 14.30

52 Week Low

₹ 1.90

Book Value Per Share

₹ 0.80

Dividend Yield

₹ 0.00

Face Value

₹₹1.00

What's Your Call?

Collective community sentiment on Gujarat Inject (Kerala) Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Gujarat Inject (Kerala) Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 Aug 2026, 8:17AM Press note/Media Released Q2 2026-2027

  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    24 Aug 2026, 12:46PM Announcement regarding enter into Strategic Business Partnership Agreement

  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    21 Aug 2026, 9:36PM Voting Results along with Scrutinizer's Report.

  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Outcome of EGM

    19 Aug 2026, 9:33PM Proceedings of Adjourned 01/2026-27 Extra Ordinary General Meeting held on Wednesday, 19th August, 2026 at 03:30 PM.

  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Outcome of EGM

    12 Aug 2026, 6:23PM EGM Adjourned due to lack of requisite quorum. The company is process to send notice to held the Adjourned EGM.

  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Change in Management

    10 Aug 2026, 6:47PM Appointment of Chief Financial Officer of the Company with effect from 10th August, 2026.

  • Gujarat Inject has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 12:50PM As of June 2026, 100.00% owned by Public. <p align=justify>

  • Gujarat Inject - 01/2026-27 Extra Ordinary General Meeting ('EGM') Of The Members Of The Company Is Scheduled To Be Held On W

    16 Jul 2026, 7:25PM 01/2026-27 Extra Ordinary General Meeting of the Company will be held on 12.08.2026 at 3:30 PM through VC/OAVM.

  • Gujarat Inject Q1 net profit zooms 1685.71% at Rs 1.25 cr

    15 Jul 2026, 10:30PM The company reported standalone net profit of Rs 1.25 crore for the quarter ended June 30, 2026 as compared to Rs 0.07 crore in the same period last y

  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 Jul 2026, 12:53PM Press Release Issued by Company.

  • Gujarat Inject - Board Meeting Outcome for OUTCOME OF BOARD MEETING

    15 Jul 2026, 10:04AM APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30.06.2026.

  • Gujarat Inject - UNAUDITED FINANCIAL RESULTS - 30.06.2026

    15 Jul 2026, 10:02AM SUBMISSION OF UNAUDITED FINANCIAL RESULTS AS ON 30.06.2026.

  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    14 Jul 2026, 3:56PM Alteration of Memorandum and Articles of association pursuant to the Change of name of the Company.

  • Gujarat Inject - Board Meeting Intimation for Consideration And Approval Of Financial Results.

    10 Jul 2026, 10:22PM Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 ,inter alia, to conside

  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Change in Management

    6 Jul 2026, 5:45PM To appoint Mr. Murli Shivshankaran Nair as an additonal Dirctor designated as Managing Director of the company

  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 Jul 2026, 1:41PM We are enclosing Media Release on Stock Split, Financial Growth and Recent Major Solar Order.

  • Guj. Inject(Kera - Corporate Action-updates on Outcome of Sub division / Stock Split

    29 Jun 2026, 4:45PM Revision in Record Date for Sub-Division/Split of Equity Shares.

  • Guj. Inject(Kera - Corporate Action-Outcome of Sub division / Stock Split

    27 Jun 2026, 6:58PM The Company has fixed Thursday, 02.07.2026 as the Record Date for determining the eligibilty of shareholders entitled to receive the benefit of sub-di

  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Cessation

    24 Jun 2026, 5:22PM Intimaion of sad demise of Mr. Deepak Diwan Bachwani, whole time director, Chief Financial Officer and Chairman of the company on 23rd June, 2026

  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    11 Jun 2026, 5:08PM The company has received a Purchase order from DEON ENERGY LIMITED for 16,129 NOS Solar PV Module. Total Value is around 14.49 Crores (exclusive of GS

  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    8 Jun 2026, 2:11PM The Company has received a Purchased Order from OTTRIVE LIFESTYLE PRIVATE LIMITED for 1334 NOS Solar PV Module. The Total Value is around 1.07 Crores
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Gujarat Inject (Kerala) Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 11.8298 10.0124 8.5453 -0.2298 -0.1441
Liabilities 11.8298 10.0124 8.5453 -0.2298 -0.1441
Equity 14.6348 14.6348 11.2923 4.8848 4.8848
Gross Profit 2.308 1.0751 0.0448 -0.3771 -0.0452
Net Profit 1.8141 1.0171 0.0827 0.041 0.0022
Cash From Operating Activities 21.2201 -1.5465 -6.0276 0.0526 -0.0002
NPM(%) 4.99 5.34 1.42 23.59 9.77
Revenue 36.3204 19.0457 5.7883 0.1738 0.0226
Expenses 34.0124 17.9706 5.7434 0.5509 0.0678
ROE(%) 15.31 8.58 0.69 0.34 0.01

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Gujarat Inject (Kerala) Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 875.00 1.94 22.00 6.33 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 108.55 1.12 1561.43 23.08 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.34 0.00 0.00 47.93 -39.50 0.00
Astec Lifesciences Ltd 554.90 -0.08 0.00 24.73 -363.14 0.00

Company Info

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Parent Organisation

Gujarat Inject (Kerala) Ltd.

Founded

07/01/1991

Managing Director

Mr.Murli Nair

NSE Symbol

FAQ